New research: Real-world study of PD-1/L1 immune checkpoint inhibitors for advanced non-small cell lung cancer after resistance to EGFR-TKIs: Background Programmed cell death-1 (PD-1) and its ligand 1 (PD-L1) inhibitors have achieved good… #oncology https
6,542 followers
279 followers
RT @Dr_Ivanoncologo: Interesting study where PD-1/L1 immune checkpoint inhibitors combined with bevacizumab in combination with platinum-co…
1,412 followers
RT @Dr_Ivanoncologo: Interesting study where PD-1/L1 immune checkpoint inhibitors combined with bevacizumab in combination with platinum-co…
3,921 followers
Interesting study where PD-1/L1 immune checkpoint inhibitors combined with bevacizumab in combination with platinum-containing two-drug chemotherapy were effective in patients with advanced #NSCLC after EGFR-TKI resistance. https://t.co/i64CdqCaFc https://